KPI data tables
Elevance Health operating metrics behind the KPI charts, newest period first (up to 24 periods per chart). Periods use each company's own fiscal labels where the source does; each table names its source.
| Period | Benefit Expense Ratio |
|---|---|
| Q3 2026 | 90.6 |
| Q2 2026 | 89.7 |
| Q1 2026 | 86.8 |
| Q4 2025 | 93.5 |
| Q3 2025 | 91.3 |
| Q2 2025 | 88.9 |
| Q1 2025 | 86.4 |
| Q4 2024 | 92.4 |
| Q3 2024 | 89.5 |
| Q2 2024 | 86.3 |
| Q1 2024 | 85.6 |
| Q4 2023 | 89.2 |
| Q3 2023 | 86.8 |
| Q2 2023 | 86.4 |
Source: Elevance Health consolidated income-statement line 'Benefit expense as a percentage of premiums' in quarterly earnings releases. Q3 2026 90.6% and Q3 2025 91.3%: Exhibit 99.1 to Form 8-K dated 21 Oct 2026, https://www.sec.gov/Archives/edgar/data/1156039/000115603926000068/a3q2026elvearningsrelease.htm. Q2 2026 89.7% and Q2 2025 88.9%: Exhibit 99.1 to Form 8-K dated 15 Jul 2026, https://www.sec.gov/Archives/edgar/data/1156039/000115603926000058/a2q2026elvearningsrelease.htm. Q1 2026 86.8%: Q1 2026 earnings release. Q4 2025 93.5% and FY 2025 90.0%; Q4 2024 92.4% and FY 2024 88.5%: Q4 2025 earnings release, https://www.sec.gov/Archives/edgar/data/1156039/000115603926000006/a4q2025elvearningsrelease.htm. Q3 2025 91.3% and Q3 2024 89.5%: Exhibit 99.1 dated 21 Oct 2025, https://www.sec.gov/Archives/edgar/data/1156039/000119312525244191/d270615dex991.htm. Q2 2025 88.9% and Q2 2024 86.3%: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000111/a2q2025elvearningsrelease.htm. Q1 2025 86.4% and Q1 2024 85.6%: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000056/a1q2025elvearningsrelease.htm. Q4 2023 89.2% and FY 2023 87.0%: Q4 2023 earnings release, https://s202.q4cdn.com/665319960/files/doc_financials/2023/q4/4Q2023_ELV_Earnings_Release.pdf. Q3 2023 86.8% from the Q3 2024 YoY column. Q2 2023 86.4% from the Q2 2024 YoY column, https://www.elevancehealth.com/content/dam/elevance-health/documents/earnings/2Q2024_ELV_Earnings_Release_Final.pdf.
| Period | Consumers Served |
|---|---|
| Q3 2026 | 91 |
| Q2 2026 | 92.4 |
| Q1 2026 | 92.9 |
| Q4 2025 | 91.8 |
| Q3 2025 | 97.6 |
| Q2 2025 | 97.3 |
| Q1 2025 | 99.5 |
| Q4 2024 | 101.1 |
| Q3 2024 | 101.3 |
| Q2 2024 | 102.3 |
| Q1 2024 | 102.9 |
Source: Elevance Health earnings-release Other Metrics line 'Carelon Services Consumers Served' (millions). Q3 2026 91.0 and Q3 2025 97.6: Exhibit 99.1 to Form 8-K dated 21 Oct 2026, https://www.sec.gov/Archives/edgar/data/1156039/000115603926000068/a3q2026elvearningsrelease.htm. Q2 2026 92.4 and Q2 2025 97.3: Exhibit 99.1 to Form 8-K dated 15 Jul 2026, https://www.sec.gov/Archives/edgar/data/1156039/000115603926000058/a2q2026elvearningsrelease.htm. Q1 2026 92.9 and Q1 2025 99.5: Q1 2026 earnings release. Q4 2025 91.8, Q4 2024 101.1, Q4 2023 103.3: Q4 2025 earnings release and FY 2025 Form 10-K Other Metrics, https://www.sec.gov/Archives/edgar/data/1156039/000115603926000013/elv-20251231.htm. Q3 2025 97.6: Exhibit 99.1 dated 21 Oct 2025. Q2 2025 97.3: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000111/a2q2025elvearningsrelease.htm. Q1 2025 99.5 and Q1 2024 102.9: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000056/a1q2025elvearningsrelease.htm. Q3 2024 101.3: https://www.sec.gov/Archives/edgar/data/1156039/000115603924000119/a3q2024elvearningsrelease.htm. Q2 2024 102.3: Q2 2024 earnings release.
| Period | Adjusted Scripts |
|---|---|
| Q3 2026 | 82.6 |
| Q2 2026 | 80.9 |
| Q1 2026 | 80.3 |
| Q4 2025 | 88.5 |
| Q3 2025 | 85 |
| Q2 2025 | 83.3 |
| Q1 2025 | 83.9 |
| Q4 2024 | 82.9 |
| Q3 2024 | 80.2 |
| Q2 2024 | 78.2 |
| Q1 2024 | 77 |
Source: Elevance Health earnings-release Other Metrics line 'CarelonRx Quarterly Adjusted Scripts' (millions). Q3 2026 82.6 and Q3 2025 85.0: Exhibit 99.1 to Form 8-K dated 21 Oct 2026, https://www.sec.gov/Archives/edgar/data/1156039/000115603926000068/a3q2026elvearningsrelease.htm. Q2 2026 80.9 and Q2 2025 83.3: Exhibit 99.1 to Form 8-K dated 15 Jul 2026, https://www.sec.gov/Archives/edgar/data/1156039/000115603926000058/a2q2026elvearningsrelease.htm. Q1 2026 80.3 and Q1 2025 83.9: Q1 2026 earnings release. Q4 2025 88.5, Q4 2024 82.9, Q4 2023 78.0: Q4 2025 earnings release and FY 2025 Form 10-K Other Metrics, https://www.sec.gov/Archives/edgar/data/1156039/000115603926000013/elv-20251231.htm. Q3 2025 85.0: Exhibit 99.1 dated 21 Oct 2025. Q2 2025 83.3: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000111/a2q2025elvearningsrelease.htm. Q1 2025 83.9 and Q1 2024 77.0: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000056/a1q2025elvearningsrelease.htm. Q3 2024 80.2: https://www.sec.gov/Archives/edgar/data/1156039/000115603924000119/a3q2024elvearningsrelease.htm. Q2 2024 78.2: Q2 2024 earnings release.
| Period | Medicaid Members |
|---|---|
| Q3 2026 | 8,220 |
| Q2 2026 | 8,358 |
| Q1 2026 | 8,456 |
| Q4 2025 | 8,500 |
| Q3 2025 | 8,645 |
| Q2 2025 | 8,733 |
| Q1 2025 | 8,862 |
| Q4 2024 | 8,917 |
| Q3 2024 | 8,926 |
| Q2 2024 | 9,028 |
| Q1 2024 | 9,327 |
| Q4 2023 | 10,503 |
Source: Elevance Health earnings-release Membership and Other Metrics tables, Medicaid line (thousands). Q3 2026 8,220 and Q3 2025 8,645: Exhibit 99.1 to Form 8-K dated 21 Oct 2026, https://www.sec.gov/Archives/edgar/data/1156039/000115603926000068/a3q2026elvearningsrelease.htm. Q2 2026 8,358 and Q2 2025 8,733: Exhibit 99.1 to Form 8-K dated 15 Jul 2026, https://www.sec.gov/Archives/edgar/data/1156039/000115603926000058/a2q2026elvearningsrelease.htm. Q1 2026 8,456: Q1 2026 earnings release. Q4 2025 8,500, Q4 2024 8,917, Q4 2023 10,503: Q4 2025 earnings release and FY 2025 Form 10-K, https://www.sec.gov/Archives/edgar/data/1156039/000115603926000013/elv-20251231.htm. Q3 2025 8,645: Exhibit 99.1 dated 21 Oct 2025. Q2 2025 8,733: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000111/a2q2025elvearningsrelease.htm. Q1 2025 8,862 and Q1 2024 9,327: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000056/a1q2025elvearningsrelease.htm. Q3 2024 8,926: https://www.sec.gov/Archives/edgar/data/1156039/000115603924000119/a3q2024elvearningsrelease.htm. Q2 2024 9,028: Q2 2024 earnings release.
| Period | Commercial Risk-Based | Commercial Fee-Based | Medicare Advantage | Medicaid | Medicare Supplement | Federal Employee Program |
|---|---|---|---|---|---|---|
| Q3 2026 | 4,714 | 27,605 | 1,898 | 8,220 | 898 | 1,547 |
| Q2 2026 | 4,734 | 27,513 | 1,897 | 8,358 | 893 | 1,554 |
| Q1 2026 | 4,863 | 27,749 | 1,899 | 8,456 | 888 | 1,563 |
| Q4 2025 | 4,924 | 27,092 | 2,230 | 8,500 | 882 | 1,604 |
| Q3 2025 | 4,970 | 27,002 | 2,245 | 8,645 | 877 | 1,630 |
| Q2 2025 | 4,963 | 27,154 | 2,255 | 8,733 | 874 | 1,642 |
| Q1 2025 | 5,061 | 27,130 | 2,255 | 8,862 | 876 | 1,649 |
| Q4 2024 | 5,000 | 27,199 | 2,066 | 8,917 | 891 | 1,661 |
| Q3 2024 | 4,971 | 27,266 | 2,047 | 8,926 | 894 | 1,656 |
| Q2 2024 | 4,929 | 27,234 | 2,031 | 9,028 | 894 | 1,660 |
| Q1 2024 | 4,894 | 27,257 | 2,017 | 9,327 | 896 | 1,658 |
| Q4 2023 | 4,781 | 26,933 | 2,047 | 10,503 | 923 | 1,642 |
Source: Elevance Health earnings-release Membership and Other Metrics tables (medical membership in thousands). Q3 2026: Exhibit 99.1 to Form 8-K dated 21 Oct 2026, https://www.sec.gov/Archives/edgar/data/1156039/000115603926000068/a3q2026elvearningsrelease.htm. Q2 2026: Exhibit 99.1 to Form 8-K dated 15 Jul 2026, https://www.sec.gov/Archives/edgar/data/1156039/000115603926000058/a2q2026elvearningsrelease.htm. Q1 2026: Q1 2026 earnings release, https://www.elevancehealth.com/content/dam/elevance-health/documents/earnings/1Q2026ELVEarningsRelease.pdf. Q4 2025 and YE 2024/2023 comparatives: Q4 2025 earnings release, https://www.sec.gov/Archives/edgar/data/1156039/000115603926000006/a4q2025elvearningsrelease.htm and FY 2025 Form 10-K membership table, https://www.sec.gov/Archives/edgar/data/1156039/000115603926000013/elv-20251231.htm. Q3 2025: Exhibit 99.1 to Form 8-K dated 21 Oct 2025, https://www.sec.gov/Archives/edgar/data/1156039/000119312525244191/d270615dex991.htm. Q2 2025: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000111/a2q2025elvearningsrelease.htm. Q1 2025 (and Q1 2024 comparatives): https://www.sec.gov/Archives/edgar/data/1156039/000115603925000056/a1q2025elvearningsrelease.htm. Q3 2024: https://www.sec.gov/Archives/edgar/data/1156039/000115603924000119/a3q2024elvearningsrelease.htm. Q2 2024: https://www.elevancehealth.com/content/dam/elevance-health/documents/earnings/2Q2024_ELV_Earnings_Release_Final.pdf. Q4 2024: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000007/a4q2024elvearningsrelease.htm.
| Period | MA Members |
|---|---|
| Q3 2026 | 1,898 |
| Q2 2026 | 1,897 |
| Q1 2026 | 1,899 |
| Q4 2025 | 2,230 |
| Q3 2025 | 2,245 |
| Q2 2025 | 2,255 |
| Q1 2025 | 2,255 |
| Q4 2024 | 2,066 |
| Q3 2024 | 2,047 |
| Q2 2024 | 2,031 |
| Q1 2024 | 2,017 |
| Q4 2023 | 2,047 |
Source: Elevance Health earnings-release Membership and Other Metrics tables, Medicare Advantage line (thousands). Q3 2026 1,898 and Q3 2025 2,245: Exhibit 99.1 to Form 8-K dated 21 Oct 2026, https://www.sec.gov/Archives/edgar/data/1156039/000115603926000068/a3q2026elvearningsrelease.htm. Q2 2026 1,897 and Q2 2025 2,255: Exhibit 99.1 to Form 8-K dated 15 Jul 2026, https://www.sec.gov/Archives/edgar/data/1156039/000115603926000058/a2q2026elvearningsrelease.htm. Q1 2026 1,899: Q1 2026 earnings release. Q4 2025 2,230, Q4 2024 2,066, Q4 2023 2,047: Q4 2025 earnings release and FY 2025 Form 10-K, https://www.sec.gov/Archives/edgar/data/1156039/000115603926000013/elv-20251231.htm. Q3 2025 2,245: Exhibit 99.1 dated 21 Oct 2025. Q2 2025 2,255: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000111/a2q2025elvearningsrelease.htm. Q1 2025 2,255 and Q1 2024 2,017: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000056/a1q2025elvearningsrelease.htm. Q3 2024 2,047: https://www.sec.gov/Archives/edgar/data/1156039/000115603924000119/a3q2024elvearningsrelease.htm. Q2 2024 2,031: Q2 2024 earnings release.